Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd

Bullboard Posts

Comment by Evo1965on Apr 16, 2018 12:44pm

95 Views

Post# 27891639

RE:RE:RE:RE:RE:RE:If your not sure

The % barite (4.45sg) is the amount of high grade barite in the zone. Take the % and multiply it by the zone length. ie. 15.22m x 37.65% = 5.73m of barite. That barite is the high grade that can be recovered. The ore is 37.65% barite over 15m. The actual barite is grading 96%-99% BaSO4. Its a breccia zone (mix of dolomite and barite) and the ore will be mined crushed and gravity seperated.

Bullboard Posts

Mastering options Greeks: Essential knowledge for informed trading